)
Investor Relations14 Oct 2025
Boost Your Earnings Season Strategy With Real‑Time Alerts
Quartr Pro provides real time alerts, trend analysis and live coverage, giving analysts and investors instant insights to act faster in earnings.
ABVC BioPharma (ABVC) investor relations material
ABVC BioPharma Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2025 earnings summary13 Aug, 2025
Executive summary
Net loss for Q2 2025 increased to $2.33M from $1.05M in Q2 2024, mainly due to higher consulting and advisory expenses.
Revenue for Q2 2025 was $0, down from $117K in Q2 2024, reflecting no milestone receipts in the period.
Total consolidated assets reached $16.2 million in Q2 2025, up 103% year-over-year, reflecting stronger affiliate equity and asset allocation.
Shareholders' equity increased to $9.5 million from $8.0 million in Q2 2024, driven by strategic consolidation and improved capital structure.
The company continues to focus on plant-derived drug and device development, with several clinical trials ongoing or planned.
Financial highlights
Q2 2025 net loss: $2.33M, up 123% from Q2 2024; six-month net loss: $3.28M, down 18% from prior year.
Q2 2025 revenue: $0; six-month 2025 revenue: $0, compared to $118K in 2024.
Operating expenses for Q2 2025: $2.29M, up from $977K in Q2 2024; six-month 2025 operating expenses: $2.99M, down from $3.82M in 2024.
Cash and cash equivalents as of June 30, 2025: $388K; working capital deficit: $3.76M.
Asset base more than doubled year-over-year, primarily due to affiliate equity and asset allocation improvements.
Outlook and guidance
Management plans to improve cash flows by collecting licensing payments, raising capital, controlling expenses, and reducing debt.
$350,000 in licensing revenue collected in July 2025 will be recognized in Q3, supporting a positive revenue outlook.
Ongoing liquidity concerns due to recurring losses and negative cash flows; ability to continue as a going concern depends on successful fundraising and operational improvements.
Several clinical trials are ongoing or planned, with potential for future milestone and royalty revenues.
Discuss the strategic rationale for Taiwan land acquisition.
How will vertical integration impact shareholder value?
Elaborate on the plans for Vitargus pivotal trials.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next ABVC BioPharma earnings date
Q3 202513 Nov, 2025
Next ABVC BioPharma earnings date
Q3 202513 Nov, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Edge3 Oct 2025
Epiroc: A Culture of Moving Mountains
From automation to electrification, Swedish industrial giant Epiroc is leading a transformation in how the world mines.
)
Company Research22 Sep 2025
Moody's: Shaping Global Credit
Explore Moody's evolution from publishing manuals to becoming a giant in credit ratings, guiding issuers, investors, and regulators worldwide.
Frequently asked questions
ABVC BioPharma Inc. is a U.S.-based biotechnology company engaged in the research, development, and commercialization of pharmaceutical and medical device products. The company focuses on advancing drug candidates and therapies in areas such as oncology, central nervous system disorders, and ophthalmology. ABVC BioPharma leverages partnerships with research institutions and healthcare organizations to develop innovative treatment solutions. ABVC BioPharma Inc. is headquartered in Fremont, California, and its shares are listed on the Nasdaq Stock Market (NASDAQ).
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage